90 related articles for article (PubMed ID: 6196269)
21. [Clinico-immunological studies of 32 cases of bone tumors].
Franchi F; Russo V; Luzi G; Santori FS; De Chiara N; Aiuti F
Minerva Med; 1980 Jun; 71(25):1815-22. PubMed ID: 6968049
[TBL] [Abstract][Full Text] [Related]
22. Clinical and immunological improvement in a patient with chronic mucocutaneous candidiasis treated with transfer factor.
Businco L; Aiuti F; Franchi F; Frati C; Cavalieri R; Rezza E
Allergol Immunopathol (Madr); 1976; 4(5):345-50. PubMed ID: 1087530
[TBL] [Abstract][Full Text] [Related]
23. E-rosette forming count determination and transfer factor treatment in herpetic simplex keratitis.
Xie LX; Kang FY; Du YX
Chin Med J (Engl); 1983 Nov; 96(11):860-4. PubMed ID: 6428821
[No Abstract] [Full Text] [Related]
24. [The erythrocyte-rosette forming cell (E-RFC) count and results of treatment with transfer factor in herpes simplex keratitis (author's transl)].
Xie LX
Zhonghua Yan Ke Za Zhi; 1981 Jul; 17(4):204-7. PubMed ID: 6802605
[No Abstract] [Full Text] [Related]
25. [Transfer factor as adjuvant immunotherapy in invasive cervix cancer. Report of a double-blind study].
Wagner G; Gitsch E; Havelec L; Knapp W; Rainer H; Selander S
Wien Klin Wochenschr; 1983 Oct; 95(20):738-42. PubMed ID: 6362210
[TBL] [Abstract][Full Text] [Related]
26. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
27. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
Lunsford LD; Flickinger JC; Larson D
Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
[TBL] [Abstract][Full Text] [Related]
28. Transfer factor therapy for histoplasmosis in a patient with Hodgkin's disease.
Catanzaro A; Spitler LE; Campbell GD; Moser KM
Arch Intern Med; 1981 Mar; 141(4):533-7. PubMed ID: 7212899
[TBL] [Abstract][Full Text] [Related]
29. [Primary infection with varicella-zoster virus in risk groups].
Jovanović J; Cvjetković D; Pobor M; Brkić S
Med Pregl; 1998; 51(3-4):151-4. PubMed ID: 9611959
[TBL] [Abstract][Full Text] [Related]
30. Transfer factor and its signification for practice.
Mrázová A; Mráz J
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1993; 36(3):117-37. PubMed ID: 8159909
[TBL] [Abstract][Full Text] [Related]
31. Postoperative immunostimulation after complete resection improves survival of patients with stage I nonsmall cell lung carcinoma.
Fujisawa T; Yamaguchi Y
Cancer; 1996 Nov; 78(9):1892-8. PubMed ID: 8909308
[TBL] [Abstract][Full Text] [Related]
32. [Human specific transfer factor to Staphylococcus aureus antigens].
Liubchenko TA; Holeva OH; Kholodna LS; Stepanchuk VA; Vershyhora AIu
Fiziol Zh (1994); 1997; 43(3-4):25-32. PubMed ID: 9303798
[TBL] [Abstract][Full Text] [Related]
33. [The isolation of a transfer factor of the delayed-hypersensitivity type to the antigenic substances of Staphylococcus aureus in guinea pigs].
Holieva OH; Liubchenko TA; Kholodna LS; Vershihora AIu
Fiziol Zh (1994); 1996; 42(5-6):58-65. PubMed ID: 9044813
[TBL] [Abstract][Full Text] [Related]
34. Anticancer Drug Development: The Way Forward.
Connors T
Oncologist; 1996; 1(3):180-181. PubMed ID: 10387985
[TBL] [Abstract][Full Text] [Related]
35. [Effect of hepatocellular carcinoma-specific transfer factor (HCC-S-TF) on IL-2 activity and IL-2R expression].
Pen GY
Zhonghua Zhong Liu Za Zhi; 1993 Nov; 15(6):435-7. PubMed ID: 8200281
[TBL] [Abstract][Full Text] [Related]
36. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
[TBL] [Abstract][Full Text] [Related]
37. Transfer factor in chronic mucocutaneous candidiasis.
Masi M; De Vinci C; Baricordi OR
Biotherapy; 1996; 9(1-3):97-103. PubMed ID: 8993766
[TBL] [Abstract][Full Text] [Related]
38. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
39. Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.
Brooks D; Taylor C; Dos Santos B; Linden H; Houghton A; Hecht TT; Kornfeld S; Taetle R
Clin Cancer Res; 1995 Nov; 1(11):1259-65. PubMed ID: 9815920
[TBL] [Abstract][Full Text] [Related]
40. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
Daoud YJ; Amin KG
Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
